These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Long-term Outcomes After Preoperative Intravitreal Injection of Bevacizumab Before Trabeculectomy for Neovascular Glaucoma. Kobayashi S; Inoue M; Yamane S; Sakamaki K; Arakawa A; Kadonosono K J Glaucoma; 2016 Mar; 25(3):281-4. PubMed ID: 25580888 [TBL] [Abstract][Full Text] [Related]
8. Combination intravitreal bevacizumab/panretinal photocoagulation versus panretinal photocoagulation alone in the treatment of neovascular glaucoma. Ehlers JP; Spirn MJ; Lam A; Sivalingam A; Samuel MA; Tasman W Retina; 2008 May; 28(5):696-702. PubMed ID: 18463512 [TBL] [Abstract][Full Text] [Related]
9. Intravitreal bevacizumab for neovascular glaucoma in uveal melanoma treated by proton beam therapy. Mahdjoubi A; Najean M; Lemaitre S; Dureau S; Dendale R; Levy C; Rouic LL; Desjardins L; Cassoux N Graefes Arch Clin Exp Ophthalmol; 2018 Feb; 256(2):411-420. PubMed ID: 29116399 [TBL] [Abstract][Full Text] [Related]
10. Anti-VEGF treatment is the key strategy for neovascular glaucoma management in the short term. Sun Y; Liang Y; Zhou P; Wu H; Hou X; Ren Z; Li X; Zhao M BMC Ophthalmol; 2016 Aug; 16(1):150. PubMed ID: 27576739 [TBL] [Abstract][Full Text] [Related]
11. Long-term results of Ahmed glaucoma valve in association with intravitreal bevacizumab in neovascular glaucoma. Sahyoun M; Azar G; Khoueir Z; Antoun J; Kourie H; Nehme J; Jalkh A J Glaucoma; 2015; 24(5):383-8. PubMed ID: 25719230 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of intravitreal bevacizumab with panretinal photocoagulation followed by Ahmed valve implantation in neovascular glaucoma. Mahdy RA; Nada WM; Fawzy KM; Alnashar HY; Almosalamy SM J Glaucoma; 2013 Dec; 22(9):768-72. PubMed ID: 22790513 [TBL] [Abstract][Full Text] [Related]
13. Management of neovascular glaucoma with panretinal photocoagulation, intravitreal bevacizumab, and subsequent trabeculectomy with mitomycin C. Alkawas AA; Shahien EA; Hussein AM J Glaucoma; 2010 Dec; 19(9):622-6. PubMed ID: 20179624 [TBL] [Abstract][Full Text] [Related]
14. Intravitreal bevacizumab for neovascular glaucoma: a randomized controlled trial. Yazdani S; Hendi K; Pakravan M; Mahdavi M; Yaseri M J Glaucoma; 2009; 18(8):632-7. PubMed ID: 19826393 [TBL] [Abstract][Full Text] [Related]
15. Management of neovascular glaucoma with transscleral cyclophotocoagulation with diode laser alone versus combination transscleral cyclophotocoagulation with diode laser and intravitreal bevacizumab. Fong AW; Lee GA; O'Rourke P; Thomas R Clin Exp Ophthalmol; 2011; 39(4):318-23. PubMed ID: 20973900 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of intravitreal bevacizumab in eyes with neovascular glaucoma undergoing Ahmed glaucoma valve implantation: 2-year follow-up. Arcieri ES; Paula JS; Jorge R; Barella KA; Arcieri RS; Secches DJ; Costa VP Acta Ophthalmol; 2015 Feb; 93(1):e1-6. PubMed ID: 24989855 [TBL] [Abstract][Full Text] [Related]
18. Surgical results of Ahmed valve implantation with intraoperative bevacizumab injection in patients with neovascular glaucoma. Ma KT; Yang JY; Kim JH; Kim NR; Hong S; Lee ES; Seong GJ; Kim CY J Glaucoma; 2012; 21(5):331-6. PubMed ID: 21673594 [TBL] [Abstract][Full Text] [Related]
19. Clinical outcomes and changes in aqueous vascular endothelial growth factor levels after intravitreal bevacizumab for iris neovascularization and neovascular glaucoma: a retrospective two-dose comparative study. Sasamoto Y; Oshima Y; Miki A; Wakabayashi T; Song D; Matsushita K; Hamasaki T; Nishida K J Ocul Pharmacol Ther; 2012 Feb; 28(1):41-8. PubMed ID: 21992534 [TBL] [Abstract][Full Text] [Related]